Clene Inc. Common Stock
$4.15
$0.29 (+7.51%)
$3.81Day Range$4.23
Key Statistics
Market Cap
$50.16M
Shares Outstanding
13.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Dec 31, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$3.86
Day High
$4.23
Day Low
$3.81
Volume
138.8K
VWAP
$4.02
Prev Close
$3.86
Transactions
--
Acc. Volume
--
About Clene Inc. Common Stock
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
PHARMACEUTICAL PREPARATIONSSIC 283479 employees6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, 84121801-676-9695IPO Dec 31, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001822791
- Composite FIGI
- BBG00X3GTK66
- Share Class FIGI
- BBG00X3GTK84
- Ticker Root
- CLNN
- SIC Code
- 2834
About Clene Inc. Common Stock (CLNN) Stock
Clene Inc. Common Stock (CLNN) closed the 2026-09-17 session at $4.15, up 7.51% versus the previous close (+0.29). The stock opened at $3.86 and traded between $3.81 and $4.23 during that session. Session trading volume was 139K shares. The volume-weighted average price (VWAP) is $4.02.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Clene Inc. Common Stock has a market capitalization of $50.2 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. CLNN is listed on the XNAS exchange. The company employs approximately 79 people. Clene Inc. Common Stock is headquartered in SALT LAKE CITY, UT. The recorded listing date is 2020-12-31.
On this page you can find market CLNN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.